Cost accounting compliance: certified cost records and annual compliance report required for covered pharmaceutical companies. Rules mandate that companies engaged in pharmaceutical activities meeting specified net worth, turnover or listing thresholds must maintain proforma-based cost records (Proformae A-I) in accordance with generally accepted cost accounting principles and applicable Cost Accounting Standards, reconcile those records with audited financial statements, retain them for at least eight years, and file a Cost Accountant-certified compliance report and annexure within 180 days of year-end; the annexure must be board-approved. Noncompliance attracts specified fines and statutory penalties.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Cost accounting compliance: certified cost records and annual compliance report required for covered pharmaceutical companies.
Rules mandate that companies engaged in pharmaceutical activities meeting specified net worth, turnover or listing thresholds must maintain proforma-based cost records (Proformae A-I) in accordance with generally accepted cost accounting principles and applicable Cost Accounting Standards, reconcile those records with audited financial statements, retain them for at least eight years, and file a Cost Accountant-certified compliance report and annexure within 180 days of year-end; the annexure must be board-approved. Noncompliance attracts specified fines and statutory penalties.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.